RankAlpha logo
Back to Rankings

AGMB

AgomAb TherapeuticsN/A
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
In line
vs peer average
AGMB vs peer average
50/100
AGMB vs. peer average (N/A vs. C)
Grade spread
A 2 · B 1 · C 2 · D 3
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

PROK is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $558.81M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerPROKProKidney
AGMB
AgomAb Therapeutics
PROK
ProKidney
Grade
N/A
D
Momentum
20
47
Value
-
41
Sentiment
-
49
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Unrated
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs PROK

AGMB / PROK
Grade Position
In line
AGMB vs. peer average (N/A vs. C)
50/100
Momentum
20
PROK
Value
-
-
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AGMB
1
PROK
ProKidney Corp Class A Common
D
40/100
-
2
ARVN
Arvinas Inc Common
C
60/100
-
3
VALN
Valneva SE ADR
C
60/100
-
4
RIGL
Rigel Pharmaceuticals Inc Common
D
40/100
-
5
GYRE
Gyre Therapeutics Inc Common
A
100/100
-
PROK is the first peer returned for this comparison set.